European Medicines Agency (EMA) Recommended Expansion of Pfizer / BioNTech Coronavirus Drug to Vaccinate Children 5-11 Years. EMA will send its recommendations to the European Commission, which will make the final decision.

Pfizer / BioNTech Vaccine Previously Approved For Use In Adults And Children 12+. As in the older group, children 5-11 years old are offered to be vaccinated in two stages with a difference of three weeks. The EMA noted that children aged 5-11 will receive a dose of vaccine that will be three times less than for people aged 12 and older.

At the end of October, the US Food and Drug Administration (FDA) approved the emergency use of the Pfizer / BioNTech vaccine for children 5-11 years old.